User profiles for Rickey E. Carter

Rickey Carter

Professor of Biostatistics, Mayo Clinic
Verified email at mayo.edu
Cited by 29629

An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome …

…, SJ Asirvatham, AJ Deshmukh, BJ Gersh, RE Carter… - The Lancet, 2019 - thelancet.com
Background Atrial fibrillation is frequently asymptomatic and thus underdetected but is
associated with stroke, heart failure, and death. Existing screening methods require prolonged …

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

…, R Marcus, NJ Gonter, M Maz, RE Carter… - Arthritis & …, 2012 - Wiley Online Library
The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). …

Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

…, A Casadevall, DL Fairweather, RE Carter… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients

…, KA Bruno, SA Klassen, RE Carter… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction

YNV Reddy, RE Carter, M Obokata, MM Redfield… - Circulation, 2018 - Am Heart Assoc
Background: Diagnosis of heart failure with preserved ejection fraction (HFpEF) is challenging
in euvolemic patients with dyspnea, and no evidence-based criteria are available. We …

Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram

…, TM Munger, SJ Asirvatham, CG Scott, RE Carter… - Nature medicine, 2019 - nature.com
Asymptomatic left ventricular dysfunction (ALVD) is present in 3–6% of the general population,
is associated with reduced quality of life and longevity, and is treatable when found 1 , 2 , …

Recommendations for planning pilot studies in clinical and translational research

CG Moore, RE Carter, PJ Nietert… - Clinical and …, 2011 - Wiley Online Library
Advances in clinical and translation science are facilitated by building on prior knowledge
gained through experimentation and observation. In the context of drug development, …

[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19

MJ Joyner, RE Carter, JW Senefeld… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience

…, NS Paneth, DL Fairweather, RS Wright, RE Carter… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

Normal-weight central obesity: implications for total and cardiovascular mortality

…, DO Hodge, RE Carter… - Annals of internal …, 2015 - acpjournals.org
Background: The relationship between central obesity and survival in community-dwelling
adults with normal body mass index (BMI) is not well-known. Objective: To examine total and …